Rockwell Medical to Showcase Innovations at ASN Kidney Week 2025

Rockwell Medical to Showcase Comprehensive Hemodialysis Concentrates Portfolio at ASN Kidney Week 2025 WIXOM, Mich. — October 29, 2025 — Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI), a global healthcare company specializing in the development, manufacture, commercialization, and distribution of…

Read More Rockwell Medical to Showcase Innovations at ASN Kidney Week 2025

Genentech Reports Positive Phase III Results for Gazyva in Youth Nephrotic Syndrome

Genentech Reports Positive Phase III Results for Gazyva in Children and Young Adults With Idiopathic Nephrotic Syndrome Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced statistically significant and clinically meaningful findings from its Phase…

Read More Genentech Reports Positive Phase III Results for Gazyva in Youth Nephrotic Syndrome
Quarter

InfuSystem to Announce Third Quarter 2025 Financial Results on November 4, 2025

InfuSystem to Report Q3 2025 Results on November 4 Rochester Hills, Mich., October 29, 2025 — InfuSystem Holdings, Inc. (NYSE American: INFU), a national healthcare service provider known for supporting outpatient care and durable medical equipment (DME) manufacturers, announced that…

Read More InfuSystem to Announce Third Quarter 2025 Financial Results on November 4, 2025